🇺🇸

US SEC Filing Intelligence

· daily

Significant Contract Modifications ($10M+) — July 30, 2026

This digest of 16 government contracts, totaling $7.45 billion, reveals an extreme concentration of awards to a single contractor—UnitedHealth Group's Optum Public Sector Solutions—which accounts for over $6.5 billion of the total across seven separate delivery orders from the Department of Veterans Affairs. The stream is overwhelmingly civilian (15 of 16 contracts), with only one defense-related award. The dominant theme is the VA's massive, short-duration outsourcing of managed healthcare services, which creates a high-conviction signal for UnitedHealth Group's federal revenue but also introduces significant risk due to the one-month performance periods and zero outlayed funds on all these awards. The key risk is execution and revenue recognition: these contracts may represent a single-month surge requirement rather than recurring business, and investors must monitor Q1 2026 earnings for confirmation of revenue.

16 total filings
· daily

S&P 500 Energy Sector SEC Filings — July 30, 2026

The S&P 500 Energy sector is showing a stark divergence between upstream M&A and downstream operational strength. Expand Energy's acquisition of Twin Eagle signals continued consolidation in the natural gas space, though the lack of disclosed financial terms creates uncertainty. Valero Energy's Q2 2026 results are the standout, with a massive earnings turnaround driven by a 48.8% revenue surge and a 5.2x increase in net income, indicating robust refining margins. The company's aggressive $2.84B in share buybacks (up 364% YoY) signals strong management confidence. However, a swing to a $198M other comprehensive loss in H1 2026 from a $721M gain warrants monitoring. Insider activity is minimal, with only a small, likely symbolic, purchase by a 10% owner at Texas Pacific Land Corp. The key portfolio-level theme is a capital allocation shift towards shareholder returns (buybacks) and strategic M&A, while operational cash flows are improving dramatically.

2 high priority 2 medium 4 total filings
· daily

Contract Deobligations Alert — July 30, 2026

This digest of 16 government contracts, totaling $7.45 billion in obligations, reveals an overwhelmingly civilian-focused procurement landscape, with only 1 of 16 contracts defense-related. The dominant investment story is the extraordinary concentration of awards to UnitedHealth Group's Optum Public Sector Solutions, which captured 9 of the 16 contracts, representing $6.49 billion (87%) of total obligation value, all from the Department of Veterans Affairs for single-month managed healthcare delivery orders. The highest-conviction signal is Optum's competitive dominance in VA managed care, winning these awards under full-and-open competition, though the extreme short-duration structure (all one-month performance periods) and zero outlayed funds introduce significant revenue recognition risk. Key risks include the lack of outlayed funds across all Optum awards, potential budget vulnerability under Continuing Resolutions, and the single-month contract structure limiting revenue visibility. The digest shows no defense sector momentum, with the lone defense-related contract (Booz Allen Hamilton, $598.7M) being a 2018 award now near expiration.

16 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — July 30, 2026

The Consumer Staples sector is exhibiting a stark divergence between pricing power and volume resilience. Hershey's strong Q2 results, driven by net price realization and productivity gains, contrast sharply with an 8% overall volume decline, signaling consumer price sensitivity. Altria's mixed performance reflects a similar dynamic: flat revenues and declining cigarette shipment volumes (-4.5% adjusted) are offset by progress in its smoke-free portfolio (Helix shipments resuming). A significant bearish signal emerged from Coca-Cola, where Chairman Quincey James executed a large insider sale (~$34.3M), the most material insider transaction in this cohort. Capital allocation trends show Hershey aggressively returning capital via buybacks ($439.4M in H1 2026) and raising dividends, while Altria maintains a steady dividend growth trajectory. The key portfolio-level theme is that companies with strong pricing power and cost discipline (Hershey) are outperforming, but volume declines remain a sector-wide risk. Forward-looking guidance from both Hershey and Altria was narrowed, indicating management confidence within a tight range, but the absence of upward revisions suggests caution.

3 high priority 2 medium 5 total filings
· daily

Contract Option Exercises — July 30, 2026

This digest covers 16 contract option exercises totaling $7.45 billion, overwhelmingly civilian (15 of 16), with the Department of Veterans Affairs as the dominant agency. The most striking pattern is UnitedHealth Group's Optum Public Sector Solutions winning eight separate delivery orders worth a combined $5.85 billion for single-month VA managed healthcare services in early 2026, representing 78% of total digest value. The highest-conviction signal is Optum's $572M February 2026 award (bullish, materiality 8/10), suggesting strong competitive positioning in federal healthcare. Key risks include the extreme short-duration structure of these contracts (all one-month performance periods) and zero outlayed funds, raising questions about revenue recognition and program continuity. The only defense-related contract is Booz Allen Hamilton's $599M GSA engineering support award, which carries a negative outlayed amount anomaly.

16 total filings
· daily

S&P 500 Industrials Sector SEC Filings — July 30, 2026

The five filings for the S&P 500 Industrials stream reveal a sector bifurcating between strong demand and margin discipline. Trane Technologies, the dominant data source, shows a powerful top-line surge (organic bookings +37%, backlog +70% to $12.1B) but is experiencing margin compression across all segments (GAAP operating margin -100 bps to 19.3%), a classic growth-at-scale challenge. Republic Services signals steady capital return with a 7.2% dividend increase, reinforcing a theme of shareholder-friendly cash deployment. Insider activity at Honeywell is purely mechanical (tax withholding on RSU vesting), offering no conviction signal. The key portfolio-level insight is that while demand is robust, cost inflation and mix shifts are pressuring profitability, creating a 'growth vs. margin' tension that investors must monitor. The forward-looking data from Trane (raised guidance) and the scheduled dividend payment from Republic Services provide clear near-term catalysts.

3 high priority 2 medium 5 total filings
· daily

Federal Professional Services Contracts — July 30, 2026

The single contract analyzed, a $598.7 million cost-plus-award-fee delivery order to Booz Allen Hamilton from the General Services Administration (GSA), represents a civilian agency award with no defense-related content. This award reinforces Booz Allen's dominant position in federal engineering services but carries execution risk due to its cost-plus pricing structure and a negative outlayed amount that may indicate funding adjustments. The contract's near-term expiration (September 2023) and the unusual negative obligation (-$218,053) warrant close monitoring for potential revenue disruption. The neutral signal strength (6/10) reflects a balanced risk-reward profile for this single, large civilian contract.

1 total filings
· daily

Federal IT & Cybersecurity Contracts — July 30, 2026

This digest covers $235.5 million in civilian agency contracts from July 2020 to March 2024, with zero defense-related awards, underscoring a pure civilian IT and cybersecurity spending theme. The dominant agencies are the IRS (Treasury) and Indian Health Service (HHS), signaling sustained investment in tax administration modernization and tribal healthcare IT. The highest-conviction signal is the $48.5 million KADIAK LLC contract with Indian Health Service, where a 'Buy Indian' set-aside provides a structural competitive moat and $42.2 million already outlayed confirms strong execution. A key risk is the $61.6 million Accenture Federal Services IRS contract, where foreign ownership and option-year reliance introduce uncertainty despite a fixed-price structure. Overall, the digest points to stable civilian IT demand but limited near-term catalysts, with average signal strength of 5.8/10 reflecting neutral-to-bullish sentiment.

4 total filings
· daily

US Material Events SEC 8-K Filings — July 30, 2026

Across the 50 filings for 2026-07-30, three dominant themes emerge: (1) active M&A and strategic transactions (ICE/MarketAxess deal, Avanos take-private, Etsy divestiture, multiple acquisitions and asset purchases), (2) capital markets activity to fund growth or shore up liquidity (registered offerings, convertible notes, credit facilities, and milestone-contingent drawdowns), and (3) leadership and governance reshuffles reflecting succession planning and operational pivots. Period-over-period comparisons show a bifurcated performance set: commodity/infrastructure and select industrials reported record quarters (Enterprise Products: net income +28% YoY; MasTec: revenue +23% YoY) while several technology and services firms reported revenue/margin softness (Forrester: revenue -10.3% YoY; Group 1 Automotive: revenue -5.6% YoY, profit decline). The most critical developments with broad market implications are ICE’s announced $5.7B purchase of MarketAxess (33% premium), which could accelerate consolidation in fixed-income marketplaces and prompt regulatory scrutiny and leverage re-rating across the sector; Enterprise Products’ record operating metrics that validate midstream resilience amid global shipping disruptions; and multiple financings (NanoViricides registered offering, T1 Energy convertible notes, Annexon $200M contingent facility) that materially change capital structures and dilution/cash runway profiles. Portfolio-level patterns: PE/strategic buyers remain active (Avanos, MarketAxess/M&A), energy & industrials show relative outperformance, while corporate boards and C-suite changes are concentrated in healthcare and industrials indicating succession readiness or cost/strategy resets. Overall, actionable signals tilt toward selectively bullish positions in high-quality energy/infrastructure names and select M&A arbitrage/credit plays, while caution is warranted in companies increasing leverage, issuing equity at narrow premiums, or showing multi-quarter margin deterioration.

50 high priority 50 total filings
· daily

All HHS Contracts — July 30, 2026

This digest covers three HHS contracts totaling $172.8 million in obligations, with one-third defense-related (BARDA biodefense awards) and two-thirds civilian (Indian Health Service IT). The dominant agency theme is HHS/BARDA pandemic preparedness, accounting for 72% of total value ($124.3M). The highest-conviction signal is KADIAK LLC's $48.5 million 'Buy Indian' set-aside contract with 87% outlayed, indicating strong execution and a structural competitive moat. Key risks include the expired $63.3 million CANGENE/EMERGENT contract with zero outlays, suggesting potential non-performance, and the cost-sharing structure of OSSIUM HEALTH's $61 million award, which compresses margins. Watch for BARDA option exercises on OSSIUM HEALTH and the February 2026 expiration of KADIAK's contract.

3 total filings
· daily

Mega Contracts Monitor ($100M+) — July 30, 2026

This digest covers $7.09 billion in mega-contracts ($100M+) awarded on July 28, 2026, with zero defense-related awards—a purely civilian government services story. The dominant theme is an extraordinary concentration of nine awards totaling $6.49 billion to UnitedHealth Group’s Optum Public Sector Solutions from the Department of Veterans Affairs, all structured as single-month, firm-fixed-price delivery orders for managed healthcare services. The highest-conviction signal is a single bullish rating on a $572.2M Optum award, reflecting strong competitive positioning and low pricing risk. However, the key risk is the extreme concentration of revenue in one-month performance periods with zero outlayed funds to date, creating significant execution and revenue recognition uncertainty for UnitedHealth Group’s federal segment.

10 total filings
· daily

General Federal Contracts — July 30, 2026

This digest covers 16 federal contracts totaling $7.45 billion, with only one defense-related award (Booz Allen Hamilton, $599M) and the overwhelming balance from civilian agencies, led by the Department of Veterans Affairs. The dominant story is a cluster of seven large, single-month firm-fixed-price delivery orders awarded to UnitedHealth Group's Optum Public Sector Solutions, collectively worth $4.85 billion for managed healthcare services in early 2026. The highest-conviction signal is the bullish $572M Optum award (materiality 8/10), indicating strong competitive positioning in VA healthcare, but the extreme concentration of revenue in a single month and zero outlayed funds across all Optum contracts introduce significant execution and revenue recognition risk. Key watch items include whether these are one-time payments or part of a recurring program, and the Booz Allen contract's negative outlayed amount (-$218K) warrants scrutiny for potential funding adjustments.

16 total filings
· daily

Insider Trading Pulse — July 30, 2026

Today's insider trading digest reveals a pronounced divergence between Asia-Pacific internet/tech and US financial/industrial sectors. In a notable cluster, all six Davey Tree Expert Co. officers simultaneously purchased shares at $23.46, signaling strong internal conviction. Conversely, massive insider selling at Coca-Cola (Chairman sold $34.3M via 10b5-1) and Richardson Electronics (CFO sold $150K after exercising cheap options) suggests profit-taking at perceived peaks. The Open Lending Corp. board and C-suite collectively disposed of over $1M in shares at $3.15, a near-unanimous exit that flags deep distress. On the bullish side, 51Talk's CEO invested $7.66M at $16.97, a high-conviction bet on the online education turnaround. The data shows a clear pattern: insiders at companies with strong cash flows (Coca-Cola, Truist) are selling or taking awards, while those at smaller, undervalued or turnaround stories (51Talk, Uranium Royalty, Davey Tree) are buying. The absence of pledges in this batch suggests no immediate liquidity stress among filers.

50 high priority 50 total filings
· daily

Dow Jones 30 Stocks SEC Filings — July 30, 2026

The six filings from Dow 30 constituents reveal a stark divergence between consumer-facing tech and industrial blue chips. Amazon and Apple delivered robust top-line growth (20% and 16% YoY, respectively), but both carry cautionary signals: Amazon's free cash flow swung to a -$7.6B outflow due to massive AI capex, while Apple's record gross margin of 50.1% was artificially boosted by ~2pp from tariff refunds, masking underlying cost pressures. Coca-Cola's chairman sold $34.3M in stock under a 10b5-1 plan, a high-materiality insider signal that warrants attention. Honeywell insider transactions were routine tax-withholding events, offering no directional insight. Alphabet's director sold a small stake, likely portfolio rebalancing. The overarching theme is that AI investment is driving a cash-flow trade-off at mega-cap tech, while consumer staples and industrials show muted insider conviction. Portfolio-level trends point to a 'growth at a cost' narrative, with investors needing to differentiate between organic strength and one-time benefits.

4 high priority 2 medium 6 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — July 30, 2026

This digest reveals a concentrated wave of distress signals across US-listed micro-cap equities, with 4 out of 5 filings detailing imminent delisting risks due to non-compliance with minimum bid price rules. The cluster of Nasdaq and NYSE deficiency notices received within a single week (July 24-29, 2026) indicates a systemic liquidity and valuation crisis among small-cap companies, rather than isolated incidents. A critical pattern emerges: while companies like Curis have technically regained compliance, they face a Draconian 'one-year Discretionary Panel Monitor' with zero tolerance for future deficiencies, effectively placing them on a permanent watchlist. The most severe case is Woodbridge Liquidation Trust, which has formally acknowledged it cannot complete its liquidation by the original deadline, seeking a three-year extension to 2030 due to a lingering construction defect claim, signaling a deeply impaired asset recovery process. The data shows no positive period-over-period trends or insider buying to offset these bearish signals; the dominant themes are capital structure erosion, regulatory overhang, and a lack of credible turnaround catalysts. The market implication is clear: these securities face a high probability of structural impairment, with delisting representing a catastrophic loss of liquidity and access to public capital markets.

5 high priority 5 total filings
· daily

US SEC Filings Daily Market Digest — July 30, 2026

Today's 50 filings reveal a market bifurcated between robust top-line growth and mounting margin pressures. While 8 of 10 reporting companies posted revenue gains (avg +9.8% YoY), 5 of 10 saw margin compression averaging -120 bps, driven by cost inflation and heavy investment. A surge in M&A activity (CRH's $8.5B Arcosa deal, SoftVest's $2.2B PBT combination, and MiMedx's Sanara acquisition) signals aggressive capital deployment in infrastructure and energy, while the tech sector shows a stark divergence between data center strength (WESCO +45% YoY, Trane +130% bookings) and consumer-facing weakness (Ambev CAC -5.4% volume, Magnum Americas -1.1% revenue). Insider activity is notably absent across filings, but capital allocation patterns are clear: buybacks and dividends are being prioritized by cash-rich firms (WTW +$1.5B buyback, Virtu $0.24 dividend), while pre-revenue biotechs (Braveheart, NanoViricides) rely on dilutive offerings. The most critical development is the Eli Lilly acquisition of atai Life Sciences at $6.75/share plus CVRs, providing a clear liquidity event in the psychedelic therapeutics space. Overall, the market is rewarding scale and pricing power while punishing margin erosion, with infrastructure and AI-related plays emerging as the clear winners.

11 high priority 39 medium 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — July 30, 2026

The three Consumer Discretionary filings reveal a sector bifurcating between AI-driven growth and legacy brand struggles. Amazon's 20% revenue surge and 43% operating income jump, fueled by AWS's 37% growth and massive AI capex, contrast sharply with Yum! Brands' mixed results where Taco Bell (+7% same-store sales) and KFC (+6% system sales) outperformed while Pizza Hut declined 2%. The most critical development is Yum!'s definitive agreement to sell Pizza Hut, signaling a strategic pivot to higher-growth concepts. Meanwhile, Booking Holdings' director sold $1M in stock under a 10b5-1 plan, adding a note of caution in the travel sector. Portfolio-level trends show strong top-line growth (Amazon +20%, Yum! +5% system sales) but diverging margin trajectories, with Amazon's operating margin expanding 220 bps while Yum!'s Pizza Hut margins compressed 14%. The overarching theme is that AI and digital transformation investments are creating winners and losers, with capital allocation increasingly favoring high-growth segments over legacy assets.

1 high priority 2 medium 3 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — July 30, 2026

The S&P 500 Healthcare sector is showing a clear divergence between top-line growth and bottom-line profitability. While 5 of 6 reporting companies posted revenue growth (Cigna +7%, Regeneron +17%, Bristol Myers +6%, Baxter +5%), margin compression is a dominant theme, with Regeneron's GAAP gross margin falling 500 bps YoY and Bristol Myers' gross margin contracting 120 bps. Forward-looking data reveals a bifurcated outlook: Cigna and Bristol Myers raised full-year guidance, while Baxter's adjusted EPS guidance implies a potential decline. Insider activity is limited but notable, with Edwards Lifesciences' CVP selling a small position. Capital allocation patterns are shifting dramatically—Cigna slashed buybacks by 90% YoY ($250M vs $2.58B), while Regeneron accelerated repurchases to nearly $2B in H1 2026. The sector is investing heavily in R&D and M&A, with Bristol Myers' R&D up 15% and Regeneron's IPR&D expenses surging 1,170%. The overall sentiment is mixed, with strong revenue growth offset by rising costs, margin pressure, and strategic repositioning.

5 high priority 6 medium 11 total filings
· daily

US Earnings Financial Results SEC Filings — July 30, 2026

This digest of 50 pre-analyzed regulatory filings for the period ending June 30, 2026, reveals a market characterized by a stark divergence in performance. While top-line revenue growth is common, with companies like Quanta Services (+41.1% YoY), PBF Energy (+56.2%), and Meta Platforms (+28%) reporting strong gains, profitability is under significant pressure from rising costs, restructuring charges, and increased capital expenditure. A key theme is the 'growth at a cost' dynamic, where aggressive investment in R&D, M&A, and infrastructure is compressing margins and straining cash flows, as seen with Meta, NextDecade, and Life Time Group. The energy sector shows a dramatic turnaround from losses to profits, while the industrial and construction sectors are booming. However, several companies are facing headwinds from currency translation, rising credit losses, and declining core business segments, creating a complex and selective investment landscape. The most critical developments include a massive insider sale at Regeneron, a significant turnaround at PBF Energy, and a sharp profit decline at Pilgrim's Pride, each with distinct market implications.

50 high priority 50 total filings